Coronavirus is on the rise in the U.S., prompting questions about when Americans can roll up their sleeves for the next COVID-19 vaccine.
COVID-19 hospitalizations have been increasing for six straight weeks. While levels remain far below previous coronavirus waves in the U.S., it’s still the first increase since winter, and it has even prompted the return of mask mandates for a handful of businesses and schools.
The Biden administration estimates that 97% of Americans ages 16 and over have some level of COVID-19 immunity through vaccination, previous infection or both. The number may sound promising – so why do people need another round of shots? Because that protection can fade in a matter of months, leaving individuals vulnerable to COVID-19 once again.
“Immunity is stronger today than at any other point in the outbreak,” Mandy Cohen, the director of the Centers for Disease Control and Prevention, said in a recent video statement. “That means we're moving towards COVID-19 being a more manageable illness with less severe illness. Having antibodies is like a shield, but we still need to be cautious because that protection does decrease over time.”
When Will the Shots Be Available?
Rollout of the shots is expected in mid-September, according to officials with the CDC and the Food and Drug Administration.
The shots from Moderna, Pfizer and Novavax first need authorization from the FDA. After that, the CDC’s committee of outside vaccine experts will gather to recommend who should be eligible for the shots. That meeting is scheduled for Sept. 12. Then, the CDC director must sign off on the recommendations before shots can be administered.
For undervaccinated or unvaccinated Americans – especially those who are at high risk for severe disease – Cohen says it might be best for them to roll up their sleeves now for the shots that are currently available.
“Those who have never been vaccinated and then some people who are older and at higher risk for a COVID infection might be best to get the existing COVID shot now and not wait,” Cohen said, noting that individuals should talk to their doctor first.
But Cohen added that “if you do get the current COVID-19 vaccine now or in early September, it could delay your ability to get this updated vaccine that's coming out in the middle of September.”
Will the Updated Boosters Work on New Coronavirus Variants?
The updated shots target XBB.1.5, which was responsible for less than 5% of new coronavirus infections in recent weeks.
The variant scene has changed significantly since the Biden administration advised vaccine makers to target the XBB strain in June. Now, EG.5, or “eris,” is the dominant strain circulating, causing over 20% of new cases.
But all the strains circulating are still descendants of omicron, so experts believe the shots will still protect against severe COVID-19 from the variants.
A Biden administration official told reporters last week, “FDA expects that once available, the updated vaccines will similarly provide protection against the most serious outcomes of the disease that may result from currently circulating variants.”
Additionally, experts are keeping a close eye on how BA.2.86, a new strain that is highly mutated, could affect the shots.
“The CDC is closely tracking a new variant which does have a number of changes or mutations that do make it distinct and different from the older versions of the virus,” Cohen said. “So we're working as fast as we can to understand this new variant and what impact it might have on how severe the COVID disease will get or how well our vaccines work against it.”
Will the New COVID-19 Shot Be Free?
Most Americans will receive the shot cost-free through their insurance. For uninsured Americans, the Biden administration is working on a program that will offer free shots at pharmacies. That program might not be available on the same day the shots are authorized but is expected to be up and running within a couple of weeks of the date.
Uninsured Americans will have immediate access to the shots for free at community health centers and individual providers as soon as they roll out.
How Many People Will Get a Booster Shot?
Historically, vaccine uptake decreases each time a new coronavirus shot is offered.
Just 17% of Americans as of May rolled up their sleeves for the latest round of shots offered. That’s a steep drop from the first shot, which saw 81% of the population roll up their sleeves.
But there are reasons to be hopeful that uptake of the shots could be higher this time around. A survey from KFF found that more than half of adults said they are likely to get another COVID-19 booster shot if it’s offered annually like the flu shot.
B |
新赛季全美直播场次公布后，联盟流量版图彻底改写。上赛季76人的全美直播场次只有14场，曝光度和话题热度一直平平无奇。随着詹姆斯加盟，76人新赛季全美直播场次直接暴涨至34场，达到联盟顶格上限，和湖人、尼克斯、勇士等传统豪门并列联盟第一。
要知道费城的城市商业体量，完全比不上洛杉矶这种顶级篮球市场。按照正常商业逻辑，湖人作为NBA老牌豪门，即便更换核心，也能稳住基本盘流量。但现实呈现出强烈反差，詹姆斯离开后，湖人的赛场曝光度以及话题热度出现了明显下滑，反观76人却实现了跨越式暴涨。
C |
这样的反差足以证明，詹姆斯自带一套体量庞大的全球流量基本盘。
D | 普通球星需要依托豪门球队放大自身影响力，詹姆斯完全相反，他走到哪，就能把聚光灯、收视率和商业资源带到哪。
E |
这也是湖人休赛期最具争议的地方，外界一直纠结球队是否该续约詹姆斯，但真正的核心问题，是湖人管理层没有看懂42岁詹姆斯的真实价值。
F | 只看年龄、薪资和常规赛场均数据，詹姆斯确实不再处于身体巅峰。但如果叠加商业价值、全球号召力、品牌影响力、年轻球迷引流能力，他的价值远超一份普通老将底薪合同。
G |
薪资表可以计算球员每场的赛场贡献，却无法核算他带来的全球曝光、商业合作、赛事收视和粉丝增量。詹姆斯的存在，不是简单的球员加盟或者转会，而是一整套成熟的顶级商业流量系统落地球队。
H |
纵观他的职业生涯，全程都是球员成就球队的范本。热火时期，他带队登顶联盟巅峰，重塑球队热度；骑士时期，他为家乡球队拿下队史首座总冠军，改写球队队史；湖人时期，他延续豪门荣光，刷新多项历史纪录；如今加盟76人，又让这支球队瞬间成为全网热议的冲冠热门。
I |
联盟大部分球星，都是背靠球队、城市、豪门底蕴才能收获关注度，詹姆斯是极少数可以反向为球队赋能的球员。这也是无数球迷愿意追随他换主队的核心原因，球迷追捧的不是城市球衣，而是陪伴了整个青春的传奇符号。
球队会更迭、城市会变迁、球衣会更换，但坚守赛场二十余年的詹姆斯，从未改变。他早已超越球员身份，成为几代球迷的青春载体。热爱从来没有对错，追随传奇更是篮球最纯粹的情怀。真正对篮球的热爱，不是固守一支球队的执念，而是认可一个人极致的自律、坚持与伟大。
兄弟们，如果你是多年的老球迷，詹姆斯如果下赛季再次换队，你会继续追随他换主队吗？你自认是纯粹的湖人球迷，还是实打实的詹姆斯球迷？欢迎在评论区聊聊你的看法！。
Current article:http://z3bvn.panningbuquanchencaibingzhang.cyou/list_7tm3ug/b481t.html
